Survival from cancer varies depending on many factors, such as demographic characteristics, tumour type, stage of the cancer at diagnosis, co-morbidities, other prognostic indic
Survival from cancer can be influenced by various factors including demographic characteristics, tumour type, stage of the cancer at diagnosis, other prognostic indicators, and
It was estimated in 2010 that alcohol-attributable cancer was responsible for about 4% of all global cancer deaths, and 5% of all potential Years-of-Life-Lost from cancer.7
In 2010, it was estimated that alcohol-attributable cancer was responsible for about 4.2% of all global cancer deaths, and 4.6% of all potential Years-of-Life-Lost as a result o
Alcohol consumption – no alcohol consumption: Proportion of people aged 18 years and over who report consuming no alcohol in the previous 12 months (including lifetime abstainer
In 2010, it was estimated that alcohol-attributable cancers represented about 4.2 percent of all global cancer deaths, and 4.6 percent of all potential ‘Years-of-Life-Lost’ as a
Cancer incidence data, as presented in this report, refer to the number of new cases of cancer diagnosed each year. They can be presented as absolute numbers or as rates.
Overweight and obesity - children and young people
2729
2254
4
Overweight and obesity is calculated using the Body Mass Index (BMI), a scale based on height and weight commonly used to indicate if a person is underweight, has normal weight,
The measure "Radiotherapy treatment activity" presents data for radiotherapy services delivered in Australia between 2013 and 2015, as indicated by reimbursement claims under th
In 2015, tobacco was the leading cause of cancer in Australia.3, 4 About 90% (Australian men) and 65% (Australian women) of lung cancers are attributable to tobacco s
It is estimated that almost 20,500 deaths in 2018, or more than one in every 8 deaths in Australia is attributable to tobacco use.3 Lung cancer accounted for almost t
This measure shows the number of people receiving at least one of the cancer-related systemic therapies and a small number of supportive treatments in Australia in any one year
